<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7444586</article-id><article-id pub-id-type="pmid">32817662</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0237959</article-id><article-id pub-id-type="publisher-id">PONE-D-20-12640</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Infectious Disease Epidemiology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Epidemiology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Respiratory Disorders</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Disorders</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>SARS coronavirus</subject><subj-group><subject>SARS CoV 2</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Population Metrics</subject><subj-group><subject>Death Rates</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>China</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Europe</subject><subj-group><subject>European Union</subject><subj-group><subject>Italy</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Geographical Locations</subject><subj-group><subject>Asia</subject><subj-group><subject>Pakistan</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide</article-title><alt-title alt-title-type="running-head">Demographic structure and SARS-CoV-2 transmission</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2512-6657</contrib-id><name><surname>Ayoub</surname><given-names>Houssein H.</given-names></name><role content-type="https://casrai.org/credit/">Data curation</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8756-6968</contrib-id><name><surname>Chemaitelly</surname><given-names>Hiam</given-names></name><role content-type="https://casrai.org/credit/">Data curation</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Seedat</surname><given-names>Shaheen</given-names></name><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mumtaz</surname><given-names>Ghina R.</given-names></name><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0138-5286</contrib-id><name><surname>Makhoul</surname><given-names>Monia</given-names></name><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0790-0506</contrib-id><name><surname>Abu-Raddad</surname><given-names>Laith J.</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Data curation</role><role content-type="https://casrai.org/credit/">Funding acquisition</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Project administration</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation &#x02013; Education City, Doha, Qatar</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine &#x02013; Qatar, Cornell University, Qatar Foundation &#x02013; Education City, Doha, Qatar</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York City, New York, United States of America</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Epidemiology and Population Health, American University of Beirut, Beirut, Lebanon</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Sartorius</surname><given-names>Benn</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of KwaZulu-Natal School of Social Sciences, SOUTH AFRICA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>hayoub@qu.edu.qa</email> (HHA); <email>lja2002@qatar-med.cornell.edu</email> (LJA)</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>20</day><month>8</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>15</volume><issue>8</issue><elocation-id>e0237959</elocation-id><history><date date-type="received"><day>30</day><month>4</month><year>2020</year></date><date date-type="accepted"><day>6</day><month>8</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Ayoub et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Ayoub et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0237959.pdf"/><abstract><p>Current geographic spread of documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections shows heterogeneity. This study explores the role of age in potentially driving differentials in infection spread, epidemic potential, and rates of disease severity and mortality across countries. An age-stratified deterministic mathematical model that describes SARS-CoV-2 transmission dynamics was applied to 159 countries and territories with a population &#x02265;1 million. Assuming worst-case scenario for the pandemic, the results indicate that there could be stark regional differences in epidemic trajectories driven by differences in the distribution of the population by age. In the African Region (median age: 18.9 years), the median <italic>R</italic><sub>0</sub> was 1.05 versus 2.05 in the European Region (median age: 41.7 years), and the median (per 100 persons) for the final cumulative infection incidence was 22.5 (versus 69.0), for severe and/or critical disease cases rate was 3.3 (versus 13.0), and for death rate was 0.5 (versus 3.9). Age could be a driver of variable SARS-CoV-2 epidemic trajectories worldwide. Countries with sizable adult and/or elderly populations and smaller children populations may experience large and rapid epidemics in absence of interventions. Meanwhile, countries with predominantly younger age cohorts may experience smaller and slower epidemics. These predictions, however, should not lead to complacency, as the pandemic could still have a heavy toll nearly everywhere.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008982</institution-id><institution>Qatar National Research Fund</institution></institution-wrap></funding-source><award-id>NPRP grant number 9-040-3-008</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0790-0506</contrib-id><name><surname>Abu-Raddad</surname><given-names>Laith J.</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008982</institution-id><institution>Qatar National Research Fund</institution></institution-wrap></funding-source><award-id>NPRP grant number 12S-0216-190094</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0790-0506</contrib-id><name><surname>Abu-Raddad</surname><given-names>Laith J.</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004800</institution-id><institution>Department for Business, Innovation and Skills</institution></institution-wrap></funding-source><award-id>Global Challenges Research Fund, grant number ES/P010873/1</award-id></award-group><funding-statement>This publication was made possible by NPRP grant number 9-040-3-008 and NPRP grant number 12S-0216-190094 from the Qatar National Research Fund (a member of Qatar Foundation). The authors are also grateful for support provided by the Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research Core, both at Weill Cornell Medicine-Qatar. GM acknowledges support by UK Research and Innovation as part of the Global Challenges Research Fund, grant number ES/P010873/1. The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The publication of this article was funded by the Qatar National Library.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="0"/><page-count count="11"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript and its Supporting Information files. The MATLAB code is available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/HousseinAyoub/COVID-19-Code.git">https://github.com/HousseinAyoub/COVID-19-Code.git</ext-link>.</meta-value></custom-meta><custom-meta id="outbreaks"><meta-name>Outbreaks</meta-name><meta-value>COVID-19</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript and its Supporting Information files. The MATLAB code is available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/HousseinAyoub/COVID-19-Code.git">https://github.com/HousseinAyoub/COVID-19-Code.git</ext-link>.</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The current geographic spread of the documented severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [<xref rid="pone.0237959.ref001" ref-type="bibr">1</xref>] infections and associated Coronavirus Disease 2019 (COVID-2019) [<xref rid="pone.0237959.ref001" ref-type="bibr">1</xref>] shows heterogeneity [<xref rid="pone.0237959.ref002" ref-type="bibr">2</xref>]. This remains unexplained but may possibly reflect delays in virus introduction into the population, differentials in testing and/or reporting, differentials in the implementation, scale, adherence, and timing of public health interventions, or other epidemiological factors. In this study, we explore the role of age in explaining the differential spread of the infection and its future epidemic potential.</p><p>As our understanding of the SARS-CoV-2 transmission dynamics is rapidly evolving [<xref rid="pone.0237959.ref003" ref-type="bibr">3</xref>], the role of age in the epidemiology of this infection is becoming increasingly apparent [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>&#x02013;<xref rid="pone.0237959.ref007" ref-type="bibr">7</xref>]. In a recent study examining SARS-CoV-2 epidemiology in China [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>], we quantified the effect of age on the <italic>biological</italic> susceptibility to infection acquisition. We found that <italic>relative</italic> to individuals aged 60&#x02013;69 years, susceptibility was 0.06 in those aged 0&#x02013;19 years, 0.34 in those aged 20&#x02013;29 years, 0.57 in those aged 30&#x02013;39 years, 0.69 in those aged 40&#x02013;49 years, 0.79 in those aged 50&#x02013;59 years, 0.94 in those aged 70&#x02013;79 years, and 0.88 in those aged &#x02265;80 years (S1 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). Notably, this age-dependence was estimated after accounting for the assortativeness in population mixing by age [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>].</p><p>Age also affects disease progression [<xref rid="pone.0237959.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0237959.ref010" ref-type="bibr">10</xref>] and mortality risk [<xref rid="pone.0237959.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0237959.ref013" ref-type="bibr">13</xref>] among those infected. The proportion of infections that eventually progress to severe disease, critical disease, or death, increases rapidly with age, especially among those &#x02265;50 years of age (S2 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>) [<xref rid="pone.0237959.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0237959.ref012" ref-type="bibr">12</xref>]. Since the demographic structure of the population (that is the distribution of the population across the different age groups) varies by country and region, this poses a question as to the extent to which age effects can drive geographic differentials in the basic reproduction number (<italic>R</italic><sub>0</sub>), epidemic potential, and rates of disease severity and mortality. <italic>R</italic><sub>0</sub> is defined here as the number of infections caused by an index case in a fully susceptible population [<xref rid="pone.0237959.ref014" ref-type="bibr">14</xref>].</p><p>We aimed here to provide an answer to this question and to estimate for each country (with a population &#x02265;1 million), region, and globally, <italic>R</italic><sub>0</sub>, and the rate per 100 persons (out of the total population by the end of the epidemic cycle) of each of the cumulative number of incident infections, mild infections, severe and/or critical disease cases, and deaths, in addition to the number of days needed for the national epidemic to reach its incidence peak (a measure of how fast the epidemic will grow).</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and methods</title><p>We adapted and applied our recently developed deterministic mathematical model [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>] describing SARS-CoV-2 transmission dynamics in China (S3 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>), to 159 countries and territories, virtually covering the world population [<xref rid="pone.0237959.ref015" ref-type="bibr">15</xref>]. Since our focus was on investigating the natural course of the SARS-CoV-2 epidemic and on assessing its full epidemic potential, the model was applied assuming the <italic>worst-case</italic> scenario for the epidemic in each country, that is in absence of any intervention.</p><p>The model stratified the population into compartments according to age (0&#x02013;9, 10&#x02013;19, &#x02026;, &#x02265;80 years), infection status (uninfected, infected), infection stage (mild, severe, critical), and disease stage (severe, critical), using a system of coupled nonlinear differential equations (Section 1 in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). Susceptible individuals in each age group were assumed at risk of acquiring the infection at a hazard rate that varies based on the age-specific susceptibility to the infection (S1 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>), the infectious contact rate per day, and the transmission mixing matrix between the different age groups (Section 1 in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). Following a latency period of 3.69 days [<xref rid="pone.0237959.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pone.0237959.ref019" ref-type="bibr">19</xref>], infected individuals develop mild, severe, or critical infection, as informed by the observed age-specific distribution of cases across these infection stages in China [<xref rid="pone.0237959.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0237959.ref010" ref-type="bibr">10</xref>]. The duration of infectiousness was assumed to last for 3.48 days [<xref rid="pone.0237959.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0237959.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0237959.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0237959.ref019" ref-type="bibr">19</xref>] after which individuals with mild infection recover, while those with severe and critical infection develop, respectively, severe and critical disease over a period of 28 days [<xref rid="pone.0237959.ref008" ref-type="bibr">8</xref>] prior to recovery. Individuals with critical disease have the additional risk of disease mortality, as informed by the age-stratified disease mortality rate in China [<xref rid="pone.0237959.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0237959.ref012" ref-type="bibr">12</xref>].</p><p>Model parameters were based on current data for SARS-CoV-2 natural history and epidemiology, or through model fitting to the China outbreak data [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>] (S1, S2 Tables in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). Namely, the overall infectious contact rate, age-specific biological susceptibility profile, and age-specific mortality rate (assuming the observed case fatality rate) were assumed as those in China [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>]. The population size, demographic structure, and life expectancy in countries and territories with a population of &#x02265;1 million, as of 2020, were extracted from the United Nations World Population Prospects database [<xref rid="pone.0237959.ref015" ref-type="bibr">15</xref>]. Whenever available data for a parameter covered a wider age bracket, we assumed that this parameter has the same value for all age groups within that bracket. Model parameters, definitions, values, and justifications are in Section B and S1, S2 Tables in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>.</p><p>Ranges of uncertainty around model-predicted outcomes were determined using five-hundred simulation runs that applied Latin Hypercube sampling [<xref rid="pone.0237959.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0237959.ref021" ref-type="bibr">21</xref>] from a multidimensional distribution of the model parameters, including both the natural history parameters and the age-specific susceptibility profile. At each run, input parameter values were selected from ranges specified by assuming &#x000b1;30% uncertainty around parameters&#x02019; point estimates [<xref rid="pone.0237959.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pone.0237959.ref026" ref-type="bibr">26</xref>]. The resulting distribution for each model-predicted outcome was then used to derive the most probable estimate (based on maximum likelihood) and 95% uncertainty interval. Mathematical modelling analyses were performed in MATLAB R2019a [<xref rid="pone.0237959.ref027" ref-type="bibr">27</xref>], while statistical analyses were performed in STATA/SE 16.1 [<xref rid="pone.0237959.ref028" ref-type="bibr">28</xref>].</p></sec><sec sec-type="results" id="sec003"><title>Results</title><p>In what follows, we highlight results for select (mostly populous) countries that are of broad geographic representation and characterized by diverse demographic structures. These include Brazil, China, Egypt, India, Indonesia, Italy, Niger, Pakistan, and USA. Estimates and uncertainty ranges for these countries are illustrated in Figs <xref ref-type="fig" rid="pone.0237959.g001">1</xref>, <xref ref-type="fig" rid="pone.0237959.g003">3</xref> and <xref ref-type="fig" rid="pone.0237959.g004">4</xref>. Detailed results for all 159 countries and territories are in S3-S8 Tables in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>.</p><fig id="pone.0237959.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237959.g001</object-id><label>Fig 1</label><caption><title>Estimates for the basic reproduction number, <italic>R</italic><sub>0</sub>, and the number of days needed for the national epidemic to reach its incidence peak, in select countries.</title></caption><graphic xlink:href="pone.0237959.g001"/></fig><p><xref ref-type="fig" rid="pone.0237959.g001">Fig 1A</xref> shows the estimated <italic>R</italic><sub>0</sub> in these select countries, which was highest in Italy at 2.30, followed by USA and China at 1.95, Brazil at 1.75, Indonesia at 1.55, India at 1.45, Egypt at 1.35, Pakistan at 1.25, and lowest in Niger at 0.93. Country-specific estimates of <italic>R</italic><sub>0</sub> grouped by World Health Organization (WHO) region are illustrated in <xref ref-type="fig" rid="pone.0237959.g002">Fig 2</xref>. The median <italic>R</italic><sub>0</sub> was 1.05 (range: 0.93&#x02013;1.95) in African Region (AFRO), 1.45 (range: 0.98&#x02013;1.75) in Eastern Mediterranean Region (EMRO), 1.55 (range: 1.15&#x02013;1.95) in South-East Asia Region (SEARO), 1.65 (range: 1.25&#x02013;2.28) in Region of the Americas (AMRO), 1.85 (range: 1.25&#x02013;2.30) in Western pacific Region (WPRO), and 2.05 (range: 1.25&#x02013;2.30) in European Region (EURO). Globally, the median <italic>R</italic><sub>0</sub> was 1.55 with a range of 0.93&#x02013;2.30.</p><fig id="pone.0237959.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237959.g002</object-id><label>Fig 2</label><caption><title>Estimates for the basic reproduction number <italic>R</italic><sub>0</sub> in 159 countries and territories with a population of at least one million, across World Health Organization regions.</title><p>These are the African Region (AFRO), Eastern Mediterranean Region (EMRO), South-East Asia Region (SEARO), Region of the Americas (AMRO), Western Pacific Region (WPRO), and European Region (EURO). The figure shows also the median age in years and the median <italic>R</italic><sub>0</sub> for each world region.</p></caption><graphic xlink:href="pone.0237959.g002"/></fig><p><xref ref-type="fig" rid="pone.0237959.g001">Fig 1B</xref> shows the estimated number of days needed for the national epidemic to reach its incidence peak in the select countries. In Italy, the peak was reached after 122 days (~4 months), whereas in Pakistan it was reached after 350 days (nearly a year). Meanwhile, since <italic>R</italic><sub>0</sub>&#x0003c;1, no epidemic would emerge in Niger. Of note that the number of days needed for the national epidemic to reach its incidence peak depends on the population size in addition to <italic>R</italic><sub>0</sub>&#x02014;it takes more time for the epidemic to reach its peak in larger nations (S3-S8 Tables in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>).</p><p>The estimated incidence rate per 100 persons in the nine select countries, defined as the <italic>cumulative</italic> number of infections by the end of the epidemic cycle out of the total population, was highest in Italy at 75.5 and lowest in Pakistan at 33.0 (<xref ref-type="fig" rid="pone.0237959.g003">Fig 3A</xref>). Across world regions, the median incidence rate per 100 persons was 22.5 (range: 0.25&#x02013;63.5) in AFRO, 45.0 (range: 1.5&#x02013;65.0) in EMRO, 49.0 (range: 25.0&#x02013;66.5) in SEARO, 53.0 in AMRO (range: 35.0&#x02013;70.5), 63.5 (range: 31.0&#x02013;76.5) in WPRO, and 69.0 (range: 31.0&#x02013;75.5) in EURO, and 49.0 (range: 0.25&#x02013;76.5) globally.</p><fig id="pone.0237959.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237959.g003</object-id><label>Fig 3</label><caption><title>Estimates for the total number of infections and the total number of deaths per 100 persons in select countries.</title></caption><graphic xlink:href="pone.0237959.g003"/></fig><p>The estimated death rate per 100 persons in the nine select countries followed the same pattern, where it was highest in Italy at 4.7 and lowest in Pakistan at 0.9 (<xref ref-type="fig" rid="pone.0237959.g003">Fig 3B</xref>). Across world regions, the median death rate per 100 persons was 0.5 (range: 0.0&#x02013;2.8) in AFRO, 0.9 (range: 0.0&#x02013;2.0) in EMRO, 1.6 (range: 0.8&#x02013;2.9) in SEARO, 2.0 in AMRO (range: 1.0&#x02013;4.2), 2.7 (range: 0.8&#x02013;5.3) in WPRO, and 3.9 (range: 0.8&#x02013;4.7) in EURO, and 1.6 (range: 0.0&#x02013;5.3) globally.</p><p>The estimated rate of mild infections per 100 persons in the nine select countries was highest in Italy at 60.5 and lowest in Pakistan at 27.0 (<xref ref-type="fig" rid="pone.0237959.g004">Fig 4A</xref>). Across world regions, the median per 100 persons was 17.0 (range: 0.25&#x02013;52.5) in AFRO, 39.0 (range: 1.5&#x02013;55.0) in EMRO, 41.0 (range: 23.0&#x02013;54.5) in SEARO, 43.5 in AMRO (range: 29.0&#x02013;56.5), 51.5 (range: 27.0&#x02013;61.5) in WPRO, and 56.5 (range: 25.0&#x02013;65.0) in EURO, and 41.0 (range: 0.25&#x02013;61.5) globally.</p><fig id="pone.0237959.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237959.g004</object-id><label>Fig 4</label><caption><title>Estimates for the total number of mild infections and the total number of severe and/or critical diseases cases per 100 persons in select countries.</title></caption><graphic xlink:href="pone.0237959.g004"/></fig><p>Meanwhile, the estimated rate of severe and/or critical disease cases per 100 persons in the nine select countries was highest in Italy at 14.7 and lowest in Pakistan at 5.0 (<xref ref-type="fig" rid="pone.0237959.g004">Fig 4B</xref>). Across world regions, the median per 100 persons was 3.3 (range: 0.0&#x02013;11.3) in AFRO, 7.1 (range: 0.3&#x02013;9.5) in EMRO, 7.7 (range: 4.1&#x02013;11.9) in SEARO, 8.7 in AMRO (range: 5.0&#x02013;13.5), 11.5 (range: 5.0&#x02013;15.5) in WPRO, and 13.0 (range: 4.7&#x02013;14.7) in EURO, and 8.0 (range: 0.0&#x02013;15.5) globally.</p></sec><sec sec-type="conclusions" id="sec004"><title>Discussion</title><p>The above results suggest that although this pandemic is a formidable challenge globally, its intensity and toll in terms of morbidity and mortality may vary substantially by country and regionally. While some countries, particularly in resource-rich countries, may experience large and rapid epidemics, other countries, particularly in resource-poor countries, may experience smaller and slower epidemics. While the scale of the epidemic may be smallest in sub-Saharan Africa with its young population, it could be intense in countries with a relatively small proportion of children and sizable proportions of adults and/or elderly.</p><p>The key finding of this study is the potential role of age in driving divergent SARS-CoV-2 epidemic trajectories and disease burdens. The effect of age reflects the interplay of three main factors: the variation in susceptibility by age (S1 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>), variation in disease severity and mortality by age (S2 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>), and variation in demographic structure across countries (S3-S8 Tables in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). The combined effect of these factors can result in stark variations in <italic>R</italic><sub>0</sub> (<xref ref-type="fig" rid="pone.0237959.g002">Fig 2</xref>), and consequently epidemic potential, disease severity, and disease mortality&#x02014;there was strong correlation between <italic>R</italic><sub>0</sub> and median age across countries (S4 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). Incidentally, the globally diagnosed cases as of July 16, 2020 show a significant correlation with median age across countries (Spearman correlation coefficient: 0.34 (95% CI: 0.19&#x02013;0.47), p&#x0003c;0.001). Although this may be explained by more diagnosed infections being reported by countries with advanced testing infrastructure, this may support the role of age presented here. Importantly, as infection transmission dynamics is a non-linear phenomenon, even small changes in <italic>R</italic><sub>0</sub>, when <italic>R</italic><sub>0</sub> is in the range of 1&#x02013;2, can drive considerable differences in epidemic size and trajectory. Variability by age, though of different magnitude, was also noted in a recent other research work [<xref rid="pone.0237959.ref007" ref-type="bibr">7</xref>].</p><p>An illustration of the role of age can be seen in Niger, a nation with a median age of only 15 years, where the exclusion of children from the population, while maintaining the same susceptibility profile for the other age groups, would have increased <italic>R</italic><sub>0</sub> from 0.93 to 2.6. This demonstrates how the lower susceptibility among younger persons, particularly children, acts as a &#x0201c;herd immunity&#x0201d; impeding the ferocious strength of the force of infection of an otherwise very infectious virus. This epidemiological feature contrasts that of other respiratory infections, such as the 2009 influenza A (H1N1) pandemic (H1N1pdm) infection (S5 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>) [<xref rid="pone.0237959.ref029" ref-type="bibr">29</xref>], where the cumulative incidence was found to be highest among children and young adults, and much smaller among older adults.</p><p>One possible inference to be drawn from the above results is that epidemic size and associated disease burden could be highest in settings with sizable mid-age and/or elderly populations, as currently exemplified by Italy. This may also possibly explain sub-national patterns, such as the large number of diagnosed cases in the city of New York, although additional fine-grained analyses are needed to delineate within-country heterogeneities in transmission dynamics.</p><p>Another possible inference of relevance to containment efforts relates to the likelihood of the infection establishing itself in a population. In addition to the role of travel patterns/restrictions and multiple introductions for seeding the infection [<xref rid="pone.0237959.ref030" ref-type="bibr">30</xref>], the probability of a major outbreak upon introduction of one infection is given approximately by 1&#x02212;1/<italic>R</italic><sub>0</sub> [<xref rid="pone.0237959.ref031" ref-type="bibr">31</xref>, <xref rid="pone.0237959.ref032" ref-type="bibr">32</xref>]. Accordingly, in countries where <italic>R</italic><sub>0</sub> is just above the epidemic threshold of <italic>R</italic><sub>0</sub> = 1, the virus will need to be introduced multiple times before it can generate sustainable chains of transmission. In such countries, less disruptive social distancing measures may be sufficient to contain the epidemic compared to countries with larger <italic>R</italic><sub>0</sub>.</p><p>Our study explores the potential effect of age on the epidemiology of SARS-CoV-2, but other factors that remain poorly understood, may also contribute to driving different epidemic trajectories. Transmission of the virus may be affected by seasonality, environmental and genetic factors, differences in social network structure and cultural norms (such as shaking hands, kissing, and other person-to-person contacts), age-dependent transmissibility effects, and underlying co-morbidities which also impact disease severity and mortality [<xref rid="pone.0237959.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0237959.ref036" ref-type="bibr">36</xref>]. These factors may have contributed to a slowly growing epidemic in Japan, despite its demographic structure, as opposed to fast growing epidemics in the European Region and the USA.</p><p>This study has limitations. Model estimations are contingent on the validity and generalizability of input data. Our estimates were based on SARS-CoV-2 natural history and disease progression data from China, but these may not be applicable to other countries. The key factor driving the heterogeneity in transmission dynamics is the age-specific biological susceptibility profile. We used the susceptibility profile as derived from the China outbreak data [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>], but this may not be generalizable to other countries. More estimates from other countries are needed to investigate the potential variation in this profile across countries, and different analytical approaches may also arrive at different estimates [<xref rid="pone.0237959.ref007" ref-type="bibr">7</xref>]. Some of the effects of biological susceptibility may simply reflect differences in social behavior or the probability of infection ascertainment. The presence and contribution of such factors are, however, difficult to disentangle.</p><p>Model 10-year age-bands were informed by available empirical evidence, which hindered analysis using narrower age intervals [<xref rid="pone.0237959.ref037" ref-type="bibr">37</xref>]. While current data on the attack rate from different countries supports age heterogeneity and lower exposure among children, different countries show still variation in the age-stratified attack rate (S6, S7 Figs in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>). Of note that the observed lower susceptibility to the infection at younger age [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>] does not necessarily imply absence of infection, but may reflect rapid infection clearance or subclinical infection. This may impact our estimates depending on these infections&#x02019; degree of infectiousness. Two sensitivity analyses assuming a 50% increase in the susceptibility of younger age cohorts or equal susceptibility among those aged &#x0003c;20 to those aged 20&#x02013;29 (to somewhat reflect the effect of subclinical infections) resulted in smaller differences in <italic>R</italic><sub>0</sub> across countries, but still supported our findings of wide heterogeneity in <italic>R</italic><sub>0</sub> (S8 and S9 Figs in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>, respectively). It is conceivable that such subclinical infections may have lower viral load, and therefore rapid infection clearance and limited transmission potential. Data on infection clusters from China and other countries suggested that children do not appear to play a significant role in the transmission of this infection [<xref rid="pone.0237959.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0237959.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0237959.ref038" ref-type="bibr">38</xref>].</p><p>Increasingly, evidence suggests that <italic>R</italic><sub>0</sub> is higher than assumed here based on fitting the China epidemic [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0237959.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0237959.ref040" ref-type="bibr">40</xref>], which would increase the <italic>R</italic><sub>0</sub> values reported here, but will not affect the relative differences across countries. We assumed a constant overall contact rate across countries, but contact rate patterns, and therefore <italic>R</italic><sub>0</sub>, can vary across and within countries [<xref rid="pone.0237959.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0237959.ref035" ref-type="bibr">35</xref>], and also over time with the implementation of interventions and associated behavioral changes [<xref rid="pone.0237959.ref041" ref-type="bibr">41</xref>]. There could be also transient effects affecting transmission patterns and epidemic dynamics [<xref rid="pone.0237959.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0237959.ref042" ref-type="bibr">42</xref>]. We assumed low degree of assortativeness in age group mixing based on fitting the China epidemic [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>], however, a sensitivity analysis assuming high assortativeness, though yielded higher estimates for <italic>R</italic><sub>0</sub>, still preserved the relative differences in these estimates across countries (S10 Fig in <xref ref-type="supplementary-material" rid="pone.0237959.s001">S1 File</xref>).</p><p>Our study may have overestimated disease mortality by basing mortality rates on estimates of the crude case fatality rate in China, as suggested by a recent study [<xref rid="pone.0237959.ref013" ref-type="bibr">13</xref>]. Our results are based on the most probable value for <italic>R</italic><sub>0</sub> as estimated through 500 runs of uncertainty analysis. The latter may have biased our reported results towards lower <italic>R</italic><sub>0</sub>. For instance, the most probable value for <italic>R</italic><sub>0</sub> in China was 1.95, but the point estimate assuming the baseline values of the input parameters was higher at 2.10 [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>]. Despite these limitations, our parsimonious model, tailored to the nature of available data, was able to reproduce the epidemic as observed in China [<xref rid="pone.0237959.ref004" ref-type="bibr">4</xref>], and generated results that are valid to a wide range of model assumptions.</p><p>Age appears to be a driver of variable SARS-CoV-2 epidemic trajectories worldwide. Countries with sizable adult and/or elderly populations and smaller children populations may experience large and rapid epidemics in absence of interventions, necessitating disruptive social distancing measures to contain the epidemic. Meanwhile, countries with predominantly younger age cohorts may experience smaller and slower epidemics and may require less disruptive social distancing measures to contain the epidemic. These predictions, however, should not lead to complacency, and should not affect national response in strengthening preparedness plans and in implementing prevention interventions, as although many countries are predicted to have lower <italic>R</italic><sub>0</sub>, these also often coincide with those having limited healthcare capacity and testing. Once established, and even if smaller in scale due to their predominantly younger population, the SARS-CoV-2 epidemic would still cause a heavy toll on developing countries with resource-poor healthcare infrastructure.</p></sec><sec sec-type="supplementary-material" id="sec005"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0237959.s001"><label>S1 File</label><caption><p>(DOCX)</p></caption><media xlink:href="pone.0237959.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ref-list><title>References</title><ref id="pone.0237959.ref001"><label>1</label><mixed-citation publication-type="other">World Health Organization (WHO). Naming the coronavirus disease (COVID-19) and the virus that causes it. <ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it</ext-link>. Accessed on March 11, 2020. 2020.</mixed-citation></ref><ref id="pone.0237959.ref002"><label>2</label><mixed-citation publication-type="other">COVID-19 Outbreak Live Update. <ext-link ext-link-type="uri" xlink:href="https://www.worldometers.info/coronavirus/">https://www.worldometers.info/coronavirus/</ext-link>. Accessed on March 27, 2020. 2020.</mixed-citation></ref><ref id="pone.0237959.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Callaway</surname><given-names>E</given-names></name>, <name><surname>Cyranoski</surname><given-names>D</given-names></name>, <name><surname>Mallapaty</surname><given-names>S</given-names></name>, <name><surname>Stoye</surname><given-names>E</given-names></name>, <name><surname>Tollefson</surname><given-names>J</given-names></name>. <article-title>The coronavirus pandemic in five powerful charts</article-title>. <source>Nature</source>. <year>2020</year>;<volume>579</volume>(<issue>7800</issue>):<fpage>482</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/d41586-020-00758-2</pub-id> .<?supplied-pmid 32203366?><pub-id pub-id-type="pmid">32203366</pub-id></mixed-citation></ref><ref id="pone.0237959.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Ayoub</surname><given-names>HH</given-names></name>, <name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Mumtaz</surname><given-names>GR</given-names></name>, <name><surname>Seedat</surname><given-names>S</given-names></name>, <name><surname>Awad</surname><given-names>SF</given-names></name>, <name><surname>Makhoul</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Characterizing key attributes of the epidemiology of COVID-19 in China: Model-based estimations</article-title>. <source>medRxiv</source>. <year>2020</year>:2020.04.08.20058214. <pub-id pub-id-type="doi">10.1101/2020.04.08.20058214</pub-id></mixed-citation></ref><ref id="pone.0237959.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Litvinova</surname><given-names>M</given-names></name>, <name><surname>Liang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Changes in contact patterns shape the dynamics of the COVID-19 outbreak in China</article-title>. <source>Science</source>. <year>2020</year>;<volume>368</volume>(<issue>6498</issue>):<fpage>1481</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb8001</pub-id>
<?supplied-pmid 32350060?><pub-id pub-id-type="pmid">32350060</pub-id></mixed-citation></ref><ref id="pone.0237959.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Mizumoto</surname><given-names>K</given-names></name>, <name><surname>Omori</surname><given-names>R</given-names></name>, <name><surname>Nishiura</surname><given-names>H</given-names></name>. <article-title>Age specificity of cases and attack rate of novel coronavirus disease (COVID-19)</article-title>. <source>medRxiv</source>. <year>2020</year>:2020.03.09.20033142. <pub-id pub-id-type="doi">10.1101/2020.03.09.20033142</pub-id></mixed-citation></ref><ref id="pone.0237959.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Davies</surname><given-names>NG</given-names></name>, <name><surname>Klepac</surname><given-names>P</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Prem</surname><given-names>K</given-names></name>, <name><surname>Jit</surname><given-names>M</given-names></name>, <collab>group CC-w</collab>, <etal>et al</etal>
<article-title>Age-dependent effects in the transmission and control of COVID-19 epidemics</article-title>. <source>Nat Med</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1038/s41591-020-0962-9</pub-id> .<?supplied-pmid 32546824?><pub-id pub-id-type="pmid">32546824</pub-id></mixed-citation></ref><ref id="pone.0237959.ref008"><label>8</label><mixed-citation publication-type="other">World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf">https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf</ext-link>. Accessed on March 10, 2020. 2020.</mixed-citation></ref><ref id="pone.0237959.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Guan</surname><given-names>WJ</given-names></name>, <name><surname>Ni</surname><given-names>ZY</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <name><surname>Liang</surname><given-names>WH</given-names></name>, <name><surname>Ou</surname><given-names>CQ</given-names></name>, <name><surname>He</surname><given-names>JX</given-names></name>, <etal>et al</etal>
<article-title>Clinical Characteristics of Coronavirus Disease 2019 in China</article-title>. <source>N Engl J Med</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id> .<?supplied-pmid 32109013?><pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="pone.0237959.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Ren</surname><given-names>L</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan</article-title>, <source>China. Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id> .<?supplied-pmid 31986264?><pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="pone.0237959.ref011"><label>11</label><mixed-citation publication-type="journal"><collab>Novel Coronavirus Pneumonia Emergency Response Epidemiology Team</collab>. [<article-title>The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China</article-title>]. <source>Zhonghua Liu Xing Bing Xue Za Zhi</source>. <year>2020</year>;<volume>41</volume>(<issue>2</issue>):<fpage>145</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0254-6450.2020.02.003</pub-id> .<?supplied-pmid 32064853?><pub-id pub-id-type="pmid">32064853</pub-id></mixed-citation></ref><ref id="pone.0237959.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>McGoogan</surname><given-names>JM</given-names></name>. <article-title>Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention</article-title>. <source>JAMA</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1001/jama.2020.2648</pub-id> .<?supplied-pmid 32091533?><pub-id pub-id-type="pmid">32091533</pub-id></mixed-citation></ref><ref id="pone.0237959.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Verity</surname><given-names>R.</given-names></name>, <name><surname>Okell</surname><given-names>L.C.</given-names></name>, <name><surname>Dorigatti</surname><given-names>I.</given-names></name>, <name><surname>Winskill</surname><given-names>P.</given-names></name>, <name><surname>Whittaker</surname><given-names>C.</given-names></name>, <name><surname>Imai</surname><given-names>N.</given-names></name>, <etal>et al</etal>
<article-title>Estimates of the severity of coronavirus disease 2019: a model-based analysis</article-title>. <source>The Lancet</source>. <year>2020</year>;<volume>20</volume>:<fpage>30243</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30243-7</pub-id>.</mixed-citation></ref><ref id="pone.0237959.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Delamater</surname><given-names>PL</given-names></name>, <name><surname>Street</surname><given-names>EJ</given-names></name>, <name><surname>Leslie</surname><given-names>TF</given-names></name>, <name><surname>Yang</surname><given-names>YT</given-names></name>, <name><surname>Jacobsen</surname><given-names>KH</given-names></name>. <article-title>Complexity of the Basic Reproduction Number (R0)</article-title>. <source>Emerg Infect Dis</source>. <year>2019</year>;<volume>25</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3201/eid2501.171901</pub-id>
<?supplied-pmid 30560777?><pub-id pub-id-type="pmid">30560777</pub-id></mixed-citation></ref><ref id="pone.0237959.ref015"><label>15</label><mixed-citation publication-type="other">United Nations Department of Economic and Social Affairs Population Dynamics. The 2019 Revision of World Population Prospects. <ext-link ext-link-type="uri" xlink:href="https://population.un.org/wpp/">https://population.un.org/wpp/</ext-link>. Accessed on March 1st, 2020. 2020.</mixed-citation></ref><ref id="pone.0237959.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Pei</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>B</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Yang</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)</article-title>. <source>Science</source>. <year>2020</year>;<volume>368</volume>(<issue>6490</issue>):<fpage>489</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb3221</pub-id> .<?supplied-pmid 32179701?><pub-id pub-id-type="pmid">32179701</pub-id></mixed-citation></ref><ref id="pone.0237959.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Lauer</surname><given-names>SA</given-names></name>, <name><surname>Grantz</surname><given-names>KH</given-names></name>, <name><surname>Bi</surname><given-names>Q</given-names></name>, <name><surname>Jones</surname><given-names>FK</given-names></name>, <name><surname>Zheng</surname><given-names>Q</given-names></name>, <name><surname>Meredith</surname><given-names>HR</given-names></name>, <etal>et al</etal>
<article-title>The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application</article-title>. <source>Ann Intern Med</source>. <year>2020</year>;<volume>172</volume>(<issue>9</issue>):<fpage>577</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.7326/M20-0504</pub-id> .<?supplied-pmid 32150748?><pub-id pub-id-type="pmid">32150748</pub-id></mixed-citation></ref><ref id="pone.0237959.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>L</given-names></name>, <name><surname>Ruan</surname><given-names>F</given-names></name>, <name><surname>Huang</surname><given-names>M</given-names></name>, <name><surname>Liang</surname><given-names>L</given-names></name>, <name><surname>Huang</surname><given-names>H</given-names></name>, <name><surname>Hong</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients</article-title>. <source>N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>12</issue>):<fpage>1177</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2001737</pub-id> .<?supplied-pmid 32074444?><pub-id pub-id-type="pmid">32074444</pub-id></mixed-citation></ref><ref id="pone.0237959.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Rothe</surname><given-names>C</given-names></name>, <name><surname>Schunk</surname><given-names>M</given-names></name>, <name><surname>Sothmann</surname><given-names>P</given-names></name>, <name><surname>Bretzel</surname><given-names>G</given-names></name>, <name><surname>Froeschl</surname><given-names>G</given-names></name>, <name><surname>Wallrauch</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany</article-title>. <source>N Engl J Med</source>. <year>2020</year>;<volume>382</volume>(<issue>10</issue>):<fpage>970</fpage>&#x02013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id> .<?supplied-pmid 32003551?><pub-id pub-id-type="pmid">32003551</pub-id></mixed-citation></ref><ref id="pone.0237959.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Mckay</surname><given-names>MD</given-names></name>, <name><surname>Beckman</surname><given-names>RJ</given-names></name>, <name><surname>Conover</surname><given-names>WJ</given-names></name>. <article-title>A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer Code</article-title>. <source>Technometrics</source>. <year>1979</year>;<volume>21</volume>(<issue>2</issue>):<fpage>239</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.2307/1268522</pub-id></mixed-citation></ref><ref id="pone.0237959.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Sanchez</surname><given-names>MA</given-names></name>, <name><surname>Blower</surname><given-names>SM</given-names></name>. <article-title>Uncertainty and sensitivity analysis of the basic reproductive rate&#x02014;Tuberculosis as an example</article-title>. <source>Am J Epidemiol</source>. <year>1997</year>;<volume>145</volume>(<issue>12</issue>):<fpage>1127</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009076</pub-id>
<?supplied-pmid 9199543?><pub-id pub-id-type="pmid">9199543</pub-id></mixed-citation></ref><ref id="pone.0237959.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Ayoub</surname><given-names>HH</given-names></name>, <name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions</article-title>. <source>BMC Med</source>. <year>2019</year>;<volume>17</volume>(<issue>1</issue>):<fpage>57</fpage>
<pub-id pub-id-type="doi">10.1186/s12916-019-1285-x</pub-id>
<?supplied-pmid 30853029?><pub-id pub-id-type="pmid">30853029</pub-id></mixed-citation></ref><ref id="pone.0237959.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Awad</surname><given-names>SF</given-names></name>, <name><surname>Sgaier</surname><given-names>SK</given-names></name>, <name><surname>Tambatamba</surname><given-names>BC</given-names></name>, <name><surname>Mohamoud</surname><given-names>YA</given-names></name>, <name><surname>Lau</surname><given-names>FK</given-names></name>, <name><surname>Reed</surname><given-names>JB</given-names></name>, <etal>et al</etal>
<article-title>Investigating Voluntary Medical Male Circumcision Program Efficiency Gains through Subpopulation Prioritization: Insights from Application to Zambia</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e0145729</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0145729</pub-id>
<?supplied-pmid 26716442?><pub-id pub-id-type="pmid">26716442</pub-id></mixed-citation></ref><ref id="pone.0237959.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Awad</surname><given-names>SF</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>The risk of HIV transmission within HIV-1 sero-discordant couples appears to vary across sub-Saharan Africa</article-title>. <source>Epidemics</source>. <year>2014</year>;<volume>6</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2013.11.001</pub-id> .<?supplied-pmid 24593916?><pub-id pub-id-type="pmid">24593916</pub-id></mixed-citation></ref><ref id="pone.0237959.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Chemaitelly</surname><given-names>H</given-names></name>, <name><surname>Awad</surname><given-names>SF</given-names></name>, <name><surname>Shelton</surname><given-names>JD</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>Sources of HIV incidence among stable couples in sub-Saharan Africa</article-title>. <source>J Int AIDS Soc</source>. <year>2014</year>;<volume>17</volume>:<fpage>18765</fpage>
<pub-id pub-id-type="doi">10.7448/IAS.17.1.18765</pub-id>
<?supplied-pmid 24560339?><pub-id pub-id-type="pmid">24560339</pub-id></mixed-citation></ref><ref id="pone.0237959.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Ayoub</surname><given-names>HH</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>. <article-title>Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention</article-title>. <source>J Viral Hepat</source>. <year>2017</year>;<volume>24</volume>(<issue>6</issue>):<fpage>486</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1111/jvh.12671</pub-id> .<?supplied-pmid 28039923?><pub-id pub-id-type="pmid">28039923</pub-id></mixed-citation></ref><ref id="pone.0237959.ref027"><label>27</label><mixed-citation publication-type="other">MATLAB<sup>&#x000ae;</sup>. The Language of Technical Computing. The MathWorks, Inc. 2019.</mixed-citation></ref><ref id="pone.0237959.ref028"><label>28</label><mixed-citation publication-type="other">StataCorp. Statistical Software: Release 16.1. College Station, TX: Stata Corporation. 2019.</mixed-citation></ref><ref id="pone.0237959.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Van Kerkhove</surname><given-names>MD</given-names></name>, <name><surname>Hirve</surname><given-names>S</given-names></name>, <name><surname>Koukounari</surname><given-names>A</given-names></name>, <name><surname>Mounts</surname><given-names>AW</given-names></name>, <collab>group HNpsw</collab>. <article-title>Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries</article-title>. <source>Influenza Other Respir Viruses</source>. <year>2013</year>;<volume>7</volume>(<issue>5</issue>):<fpage>872</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1111/irv.12074</pub-id>
<?supplied-pmid 23331969?><pub-id pub-id-type="pmid">23331969</pub-id></mixed-citation></ref><ref id="pone.0237959.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Gilbert</surname><given-names>M</given-names></name>, <name><surname>Pullano</surname><given-names>G</given-names></name>, <name><surname>Pinotti</surname><given-names>F</given-names></name>, <name><surname>Valdano</surname><given-names>E</given-names></name>, <name><surname>Poletto</surname><given-names>C</given-names></name>, <name><surname>Boelle</surname><given-names>PY</given-names></name>, <etal>et al</etal>
<article-title>Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10227</issue>):<fpage>871</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30411-6</pub-id>
<?supplied-pmid 32087820?><pub-id pub-id-type="pmid">32087820</pub-id></mixed-citation></ref><ref id="pone.0237959.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Whittle</surname><given-names>P</given-names></name>. <article-title>The Outcome of a Stochastic Epidemic</article-title>. <source>Biometrika</source>. <year>1955</year>;<volume>42</volume>(<issue>1&#x02013;2</issue>):<fpage>116</fpage>&#x02013;<lpage>22</lpage>.</mixed-citation></ref><ref id="pone.0237959.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Allen</surname><given-names>LJS</given-names></name>, <name><surname>Lahodny</surname><given-names>GE</given-names></name>. <article-title>Extinction thresholds in deterministic and stochastic epidemic models</article-title>. <source>J Biol Dynam</source>. <year>2012</year>;<volume>6</volume>(<issue>2</issue>):<fpage>590</fpage>&#x02013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1080/17513758.2012.665502</pub-id>
<?supplied-pmid 22873607?><pub-id pub-id-type="pmid">22873607</pub-id></mixed-citation></ref><ref id="pone.0237959.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Kissler</surname><given-names>SM</given-names></name>, <name><surname>Tedijanto</surname><given-names>C</given-names></name>, <name><surname>Goldstein</surname><given-names>E</given-names></name>, <name><surname>Grad</surname><given-names>YH</given-names></name>, <name><surname>Lipsitch</surname><given-names>M</given-names></name>. <article-title>Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period</article-title>. <source>Science</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1126/science.abb5793</pub-id>
<?supplied-pmid 32291278?><pub-id pub-id-type="pmid">32291278</pub-id></mixed-citation></ref><ref id="pone.0237959.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Mossong</surname><given-names>J</given-names></name>, <name><surname>Hens</surname><given-names>N</given-names></name>, <name><surname>Jit</surname><given-names>M</given-names></name>, <name><surname>Beutels</surname><given-names>P</given-names></name>, <name><surname>Auranen</surname><given-names>K</given-names></name>, <name><surname>Mikolajczyk</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Social contacts and mixing patterns relevant to the spread of infectious diseases</article-title>. <source>Plos Med</source>. <year>2008</year>;<volume>5</volume>(<issue>3</issue>):<fpage>381</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.0050074</pub-id>
<?supplied-pmid 18366252?><pub-id pub-id-type="pmid">18366252</pub-id></mixed-citation></ref><ref id="pone.0237959.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Prem</surname><given-names>K</given-names></name>, <name><surname>Cook</surname><given-names>AR</given-names></name>, <name><surname>Jit</surname><given-names>M</given-names></name>. <article-title>Projecting social contact matrices in 152 countries using contact surveys and demographic data</article-title>. <source>Plos Computational Biology</source>. <year>2017</year>;<volume>13</volume>(<issue>9</issue>). <pub-id pub-id-type="doi">10.1371/journal.pcbi.1005697</pub-id>
<?supplied-pmid 28898249?><pub-id pub-id-type="pmid">28898249</pub-id></mixed-citation></ref><ref id="pone.0237959.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Viner</surname><given-names>RM</given-names></name>, <name><surname>Mytton</surname><given-names>OT</given-names></name>, <name><surname>Bonell</surname><given-names>C</given-names></name>, <name><surname>Melendez-Torres</surname><given-names>GJ</given-names></name>, <name><surname>Ward</surname><given-names>JL</given-names></name>, <name><surname>Hudson</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Susceptibility to and transmission of COVID-19 amongst children and adolescents compared with adults: a systematic review and meta-analysis</article-title>. <source>medRxiv</source>. <year>2020</year>:2020.05.20.20108126. <pub-id pub-id-type="doi">10.1101/2020.05.20.20108126</pub-id></mixed-citation></ref><ref id="pone.0237959.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Goldstein</surname><given-names>E</given-names></name>, <name><surname>Lipsitch</surname><given-names>M</given-names></name>. <article-title>Temporal rise in the proportion of younger adults and older adolescents among coronavirus disease (COVID-19) cases following the introduction of physical distancing measures, Germany, March to April 2020</article-title>. <source>Eurosurveillance</source>. <year>2020</year>;<volume>25</volume>(<issue>17</issue>):<fpage>2</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="pone.0237959.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Zhu</surname><given-names>Y</given-names></name>, <name><surname>Bloxham</surname><given-names>CJ</given-names></name>, <name><surname>Hulme</surname><given-names>KD</given-names></name>, <name><surname>Sinclair</surname><given-names>JE</given-names></name>, <name><surname>Tong</surname><given-names>ZWM</given-names></name>, <name><surname>Steele</surname><given-names>LE</given-names></name>, <etal>et al</etal>
<article-title>Children are unlikely to have been the primary source of household SARS-CoV-2 infections</article-title>. <source>medRxiv</source>. <year>2020</year>:2020.03.26.20044826. <pub-id pub-id-type="doi">10.1101/2020.03.26.20044826</pub-id></mixed-citation></ref><ref id="pone.0237959.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>W</given-names></name>, <name><surname>Yi</surname><given-names>GY</given-names></name>, <name><surname>Zhu</surname><given-names>Y</given-names></name>. <article-title>Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis</article-title>. <source>J Med Virol</source>. <year>2020</year>
<pub-id pub-id-type="doi">10.1002/jmv.26041</pub-id>
<?supplied-pmid 32470164?><pub-id pub-id-type="pmid">32470164</pub-id></mixed-citation></ref><ref id="pone.0237959.ref040"><label>40</label><mixed-citation publication-type="other">MIDAS Online COVID-19 Portal. COVID-19 parameter estimates: basic reproduction number. <ext-link ext-link-type="uri" xlink:href="https://github.com/midas-network/COVID-19/tree/master/parameter_estimates/2019_novel_coronavirus">https://github.com/midas-network/COVID-19/tree/master/parameter_estimates/2019_novel_coronavirus</ext-link>. Accessed on: MAy 19, 2020. 2020.</mixed-citation></ref><ref id="pone.0237959.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Riccardo</surname><given-names>F</given-names></name>, <name><surname>Ajelli</surname><given-names>M</given-names></name>, <name><surname>Andrianou</surname><given-names>X</given-names></name>, <name><surname>Bella</surname><given-names>A</given-names></name>, <name><surname>Del Manso</surname><given-names>M</given-names></name>, <name><surname>Fabiani</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Epidemiological characteristics of COVID-19 cases in Italy and estimates of the reproductive numbers one month into the epidemic</article-title>. <source>medRxiv</source>. <year>2020</year>:2020.04.08.20056861. <pub-id pub-id-type="doi">10.1101/2020.04.08.20056861</pub-id></mixed-citation></ref><ref id="pone.0237959.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Adhikari</surname><given-names>R</given-names></name>, <name><surname>Bolitho</surname><given-names>A</given-names></name>, <name><surname>Caballero</surname><given-names>F</given-names></name>, <name><surname>Cates</surname><given-names>ME</given-names></name>, <name><surname>Dolezal</surname><given-names>J</given-names></name>, <name><surname>Ekeh</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Inference, prediction and optimization of non-pharmaceutical interventions using compartment models: the PyRoss library</article-title>. <source>arXiv: Populations and Evolution</source>. <year>2020</year>.</mixed-citation></ref></ref-list></back></article>